Balazs Szigeti is involved in the Imperial College London-Beckley self-blinding microdosing study that at this moment hasn’t found significant effects of microdosing.
Balazs Szigeti has earned a bachelor’s and master’s in mathematical physics from Imperial College London and then completed his PhD in computational neuroscience at the University of Edinburgh.
Balazs has been involved with the OpenWorm project, an open science project aimed to create accurate simulations of primitive nervous systems. He also used to work as a biomedical software engineer at the Icahn Institute of Genetics in New York.
He has collaborated with the Global Drug Survey to quantitatively study drug use patterns and most recently he designed and led the Imperial College-Beckley self-blinding microdose study.